Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501) (Q36498968)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501) |
scientific article |
Statements
Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501) (English)
Ann LaCasce
Kristie A Blum
Vicki A Morrison
Sin-Ho Jung
Jeffrey Johnson
Brandelyn N Pitcher
1 reference
1 reference
1 reference
1 reference